BDBM42274 N-(4-((S)-2-(5-Chloropyridin-2-yl)propyl)-6-(((R)-1-hydroxy-4-methylpentan-2-yl)amino)-1,3,5-triazin-2-yl)methanesulfonamide::WO2024083933, Example 149

SMILES ClC=1C=CC(=NC1)[C@H](CC1=NC(=NC(=N1)N[C@@H](CO)CC(C)C)NS(=O)(=O)C)C

InChI Key InChIKey=FYANNMRFPSTTNG-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 42274   

TargetCX3C chemokine receptor 1(Human)
Astrazeneca

WIPO
LigandChemical structure of BindingDB Monomer ID 42274BDBM42274(N-(4-((S)-2-(5-Chloropyridin-2-yl)propyl)-6-(((R)-...)
Affinity DataIC50: 3.00E+4nMAssay Description:The mutation underlying Huntington's disease is an expansion of a polyglutamine tract in the N-terminus of the protein huntingtin (htt). Under no...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/23/2026
Entry Details
US Patent